First-time disclosure of IPN60090, a potent and selective GLS1 inhibitor with excellent physicochemical properties, targeting cancers with specific metabolic vulnerabilities

Gang Liu

Jeffrey Kovacs

Jennifer P. Bardenhagen

Christopher Bristow

Barbara Czako

Maria Di Francesco

Matthew M. Hamilton

Mary Geck Do

Angela Harris

Virginia Giuliani

Sha Huang

Yongying Jiang

Troy Johnson

Zhijun Kang

Zhen Liu

Meredith Miller

Pietro Morlacchi

Jihai Pang

Hannah E. Shepard

Nakia Spencer

Jay Theroff

Anne Yau

Giulio Draetta

Carlo Toniatti

Natalya Nazarenko

Philip Jones

0 views
0 downloads

Powered byMorressier logo black

Discover more research and events on morressier.com